Climb Bio, Inc. (CLYM) Q4 2024 Annual Earnings
CLYM·Reported March 25, 2025·Before market open
Diluted EPS came in at $-0.13, beat the $-0.15 consensus by $0.02.
Diluted EPS
$-0.13beat by $0.02
Consensus: $-0.15
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Climb Bio, Inc.'s Q4 2024 earnings report.
Climb Bio, Inc. (CLYM) reported Q4 2024 earnings on March 25, 2025 before market open.
Climb Bio, Inc. reported diluted EPS of $-0.13 for Q4 2024.
EPS beat the consensus estimate of $-0.15 by $0.02.
You can read the 10-K periodic report (0000950170-25-044350) directly on SEC EDGAR. The filing index links above go to sec.gov.